U.S. FTC Approves Hikma Deal For Custopharm With Conditions
WASHINGTON (Reuters) – Generic drug maker Hikma Pharmaceuticals has won U.S. antitrust approval to buy Custopharm, Inc on condition that…
April 19, 2022
Netflix Earnings Coming Up
Key Earnings You Must Watch Earnings season is upon us. Markets have been battered with cautious macro headlines over the…
Fed’s Evans Sees Year-end Rates At 2.25%-2.5%, And Then Likely Higher
By Ann Saphir (Reuters) -Chicago Federal Reserve Bank President Charles Evans on Tuesday said the Fed could raise its policy…
Twitter Co-founder Dorsey Takes Aim At Board In Series Of Tweets
(Reuters) – Twitter Inc co-founder Jack Dorsey took aim at the social media company’s board in a series of tweets…
Deliveroo Found Guilty Of Abusing Riders’ Rights In France
By Mathieu Rosemain PARIS (Reuters) – Two former bosses of Deliveroo were given suspended one-year prison sentences and fined 30,000…
Analysis-Twitter Exploring A Sale Would Make Free Speech An Afterthought
By Tom Hals and Jessica DiNapoli (Reuters) – Twitter Inc’s board directors can lean on concerns about the fate of…
J&J Suspends COVID Vaccine Sales Forecast On Low Demand, Supply Glut
By Manas Mishra (Reuters) -Johnson & Johnson on Tuesday said it could no longer provide a forecast for sales of…
Tesla Moves To Pause California Agency’s Race Bias Lawsuit
By Daniel Wiessner (Reuters) – Tesla Inc has asked a California judge to pause a state agency’s lawsuit that accuses…
Wall Street, Bond Yields Head Higher As Global Growth Hopes Trimmed
By Samuel Indyk and Pete Schroeder LONDON/WASHINGTON (Reuters) -Wall Street opened higher on Tuesday and bond yields continued to swing…
Tesla Earnings May Come Under Pressure From Shanghai Factory Halt
By Hyunjoo Jin and Nivedita Balu SAN FRANCISCO (Reuters) -Tesla investors on Wednesday will be keeping an eye on whether…